ARTIFICIAL INTELLIGENCE TOOLS IN POST-PROCESSING ANALYSIS OF NEUROIMAGING: A REVIEW OF THE LAST DECADE (2016–2026)
Study Design & Technical Specifications
Sample Size / Cohort
1 Data Files
Subject / Study Model
CNS Experimental / Clinical Model
Analytical Modalities
Primary Abstract & Repository Description
Source: Zenodo (CERN Open Data)Editorial Critique, Methodological Value & Reusability Guide
1. Scientific Context & Premise
Primary Premise (Zenodo (CERN Open Data)): "Post-processing of neuroimaging data — the segmentation, quantification, and volumetric or perfusion analysis performed after an MRI or CT scan is acquired — has traditionally relied on manual or semi-automated work by radiologists and neurologists." Within Multiple Sclerosis (MS), this work examines Zenodo, Open Dataset in relation to paramagnetic rim lesions (PRLs), T2/FLAIR lesion volume, oligoclonal bands, EBV titers, and EDSS progression metrics. Authored by Shukrulloh Toshqulov, Sultonova Dilbar Azamatovna, Worldly Knowledge Publishing Centre.
2. Study Architecture & Findings
Study Architecture: Experimental / Clinical CNS Design (1 Data Files) utilizing Structural MRI [DOI: 10.5281/zenodo.23835285]. Key reported conclusion: "Overall, the literature indicates that deep learning..."
3. Secondary Analysis & Reusability
Secondary Analysis Applications: (1) Cross-referencing Structural MRI variables (Zenodo, Open Dataset) against open repositories in Multiple Sclerosis (MS); (2) Benchmarking feature distributions and effect sizes reported in "ARTIFICIAL INTELLIGENCE TOOLS IN POST-PROCESSING ANALYSIS OF NEUROIMAGING: A REV"; (3) Informing cohort stratification and endpoint selection.
4. Methodological Caveats & Governance
Methodological Note: When integrating these Structural MRI findings, account for cohort-specific inclusion criteria (1 Data Files), potential site/instrument batch effects, and repository license terms (CC-BY-4.0).
Data Access, Reproducibility & Analysis Starter Guide
BIDS (Brain Imaging Data Structure) v1.9+
Quick Data Access & Structured Export
Open the primary repository directly or download structured metadata (JSON / CSV) in one click.
This neuroimaging resource follows the Brain Imaging Data Structure (BIDS) specification, organizing raw NIfTI volumes (.nii.gz), acquisition parameters (.json sidecars), and participant phenotype tables (participants.tsv) in a deterministic directory hierarchy.
Programmatic Data Retrieval (Python Starter Code & Recommended SDKs)
Python Quickstart: Download & Inspect BIDS Neuroimaging Dataset
# 1. Install BIDS & Neuroimaging dependencies
# pip install openneuro-py pybids nibabel pandas
import openneuro as on
from bids import BIDSLayout
import pandas as pd
# Download metadata & subject headers from OpenNeuro (ds004500)
dataset_id = "ds004500"
target_dir = f"./data/{dataset_id}"
on.download(dataset=dataset_id, target_dir=target_dir, include=["participants.tsv", "dataset_description.json", "sub-01/*"])
# Initialize PyBIDS layout and inspect subjects & modalities
layout = BIDSLayout(target_dir, validate=False)
print(f"Subjects: {layout.get_subjects()} | Modalities: {layout.get_datatypes()}")
# Load clinical / demographic phenotype table
participants = pd.read_csv(f"{target_dir}/participants.tsv", sep="\t")
print(participants.head())Standardized 4-Step Workflow & Governance Checklist
Standardized Acquisition & Preprocessing Workflow
1. Retrieve BIDS Hierarchy via DataLad or AWS S3 CLI
Fetch the dataset manifest and selectively download subject anatomical/functional runs without requiring authentication credentials.
2. Run BIDS-Validator & Inspect JSON Sidecars
Verify TR (Repetition Time), TE, slice timing, and scanner field strength (3T/7T) across all subjects to detect protocol deviations.
3. Standardized Preprocessing (fMRIPrep / FreeSurfer)
Execute motion correction, susceptibility distortion correction, and MNI152NLin2009cAsym template normalization.
4. Covariate Regression & Group-Level Modeling
Merge participants.tsv clinical scores with extracted ROI/parcellation metrics while controlling for age, sex, and head motion.
Reproducibility & Governance Checklist
- Verify BIDS dataset_description.json License and HowToAcknowledge fields before publication.
- Exclude runs exceeding framewise displacement (FD > 0.5 mm) to prevent motion-induced false positives.
- Ensure all anatomical scans remain defaced/de-identified in derivative repositories.
Tags & Modalities
Related Multiple Sclerosis Research & Datasets
Explore All DatasetsMSDA: COVID19 GDSI LocalDashboard - Federated MS Data Toolkit
Official open-source repository and tool for Multiple Sclerosis federated research and data harmonization under MS-DATA-ALLIANCE.
CNM-Au8 Treatment Is Associated With Reduced Chronic Lesion Tissue Expansion in Relapsing-Remitting Multiple Sclerosis
BackgroundCNM-Au8, a catalytic nanocrystalline gold suspension, is proposed to support neuronal bioenergetics, but its effect on chronic lesion evolution in multiple sclerosis (MS) has not been reported. ObjectivesTo evaluate the effect of CNM-Au8 on chronic lesion tissue expansion (CLTE). Results...
Global Data Sharing Initiative (GDSI): Containerized Federated Analysis Pipeline for MS Registries
International federated research initiative and containerized query framework allowing participating national MS registries to analyze disease-modifying therapy (DMT) safety, anti-CD20 outcomes, and PIRA progression without transferring identifiable patient data.
Multiple Sclerosis and Viruses: « Liaisons Dangereuses ».
Multiple sclerosis (MS) is a complex, multifactorial neurodegenerative disease with an aetiology that is still partially elusive. Several risk factors are associated with MS development including genetic predisposition and various environmental stressors; however, recently, viral infections have gained significant attention as a crucial environmental trigger. Despite the well-established link between Epstein-Barr virus (EBV) and MS susceptibility, a single-pathogen model fails to clearly characterise the molecular cascades driving the disease, suggesting that the transition from infection to autoimmune response involves more than one viral agent. In this review we examine the speculation that the interactions among different neurotropic viruses could serve a collective causative role in MS, which is under-researched in the literature at present. We summarise contradictory evidence on the role of different viral agents, including the Herpesviridae family (Human Cytomegalovirus, EBV, Herpes Simplex Viruses HSV-1 and HSV-2, and Varicella Zoster Virus), Paramyxoviridae family (Measles Virus and Rubella Virus), Influenza virus, SARS-CoV-2, and Human Endogenous Retroviruses (HERVs). Through interplay within shared molecular pathways, immune modulation, and activation of latent infections, these viruses may collectively influence the inflammatory and demyelinating processes that characterise MS. This review evaluates the etiological role of viral interplay in MS through the cumulative and interactive effects of these pathogens. The available epidemiological, immunological, and experimental data converge on the concept that viral co-exposures act synergistically to shape MS susceptibility in genetically predisposed individuals. Characterising these viral interactions presents a new research direction for the identification of novel biomarkers and the development of preventative strategies through the targeted control of viral networks.
MSDA Core Dataset (CDS): Standardized Global Real-World Data Harmonization Framework for Multiple Sclerosis
The MSDA Core Dataset (CDS) establishes a 44-variable international harmonization schema mapped to the OMOP Common Data Model, enabling privacy-preserving federated analytics across global Multiple Sclerosis registries.
MSDA Global Registry & Cohort Metadata Discovery Catalogue (BigMS Network)
A centralized metadata discovery catalogue indexing over 30 national and international MS registries (>120,000 patients), detailing variable availability for EDSS, relapse history, MRI, fluid biomarkers, and DUA governance.
Active Clinical Trials & Pipeline in Multiple Sclerosis
View Clinical PipelineNCT06463743: Metformin as an add-on or Monotherapy in Treatment of Aging People With Multiple Sclerosis (MS)
NCT06329414: Acceptability and Feasibility of Transcranial Magnetic Stimulation (TMS) for Depression in Multiple Sclerosis
NCT07766213: Pain Phenotypes in Individuals With Multiple Sclerosis
Related Data & Resources
Academic Research & Medical Information Disclaimer
This page provides structured scientific metadata, methodological critiques, and open-data reusability guidelines intended strictly for neuroscience researchers and data scientists. It does not constitute medical advice, clinical diagnosis, or treatment recommendations.
Was this resource helpful?
Help improve data curation by sharing your feedback.